HealthcareServices

Biologics Testing Industry Growth Insights: Revenue Forecast to 2030

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biologics testing market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Biologics Testing Market covering 2026–2035?

The size of the biologics testing market has experienced significant expansion over recent years. It is anticipated to expand from $6.83 billion in 2025 to $7.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.0%. Factors contributing to its historical growth include an increase in biologics manufacturing volumes, the expansion of vaccine development programs, heightened regulatory expectations regarding product safety, broader adoption of monoclonal antibody therapies, and the rise of contract testing laboratories.

The biologics testing market is projected to experience substantial expansion in the coming years. This market is forecast to reach $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This anticipated growth is primarily driven by factors such as a surge in demand for rapid release testing, the increasing implementation of automated quality control systems, the expanding requirements for cell and gene therapy testing, an amplified emphasis on data integrity, and greater investments in digital laboratory infrastructure. Key trends observed within this timeframe encompass the increasing utilization of advanced analytical testing platforms, a heightened demand for thorough biologics quality testing, the expanding application of high-sensitivity assays, the proliferation of outsourced testing services, and a strengthened focus on testing for regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Biologics Testing Market?

The biologics testing market is anticipated to expand due to the swift expansion of the pharmaceutical and biotechnology sectors. The pharmaceutical industry primarily concentrates on creating and producing medicines for diverse ailments and health issues. Conversely, the biotechnology industry centers on applying technology to biological sciences and healthcare. Biologics testing encompasses evaluations to detect and measure impurities, determine stability, and gauge the immune reaction to a drug. The expansion of these industries has also spurred progress in biologics testing technology, such as the creation of novel analytical instruments and methods. This progress has facilitated more precise and effective testing, thereby cutting down the duration and expense of introducing new biologics to the market. For example, in July 2024, Eurostat, a governing body located in Belgium, reported that pharmaceutical output in the EU surged to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the field. Consequently, the rapid development of the pharmaceutical and biotechnology industries is fueling the growth of the biologics testing market.

What Segments Are Identified Within The Structure Of The Biologics Testing Market?

The biologics testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Other Products

2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

3) By Other Products: Software, Consumables, Reference Standards

Which Trends Are Expected To Influence The Biologics Testing Market In The Upcoming Years?

Leading companies in the biological testing market are developing novel technologies, such as protein engineering techniques, to enhance their market profitability. Protein engineering involves the design and modification of proteins to generate new or improved versions with specific desired attributes. For example, in July 2023, Queensland University of Technology, an Australia-based university, introduced an innovative protein-engineering technique enabling the swift and precise creation of new diagnostic tests. This technology provides a fresh approach for improving and expanding laboratory testing, which is expected to have a notable positive influence on both health and the economy.

Which Key Market Players Are Investing In Expansion And Innovation Within The Biologics Testing Market?

Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Which Regions Are Poised For Strategic Growth In The Biologics Testing Market?

North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biologics Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

Biologics Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Biologics Contract Development Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Veterinary Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795